Koch H - Search Results

1

Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma.

Hau P, Koch D, Hundsberger T, Marg E, Bauer B, Rudolph R, Rauch M, Brenner A, Rieckmann P, Schuth J, Jauch T, Koch H, Bogdahn U. Hau P, et al. Among authors: koch h, koch d. Neurology. 2007 Feb 27;68(9):688-90. doi: 10.1212/01.wnl.0000255937.27012.ee. Neurology. 2007. PMID: 17325277 Clinical Trial.

2

Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study.

Wismeth C, Hau P, Fabel K, Baumgart U, Hirschmann B, Koch H, Jauch T, Grauer O, Drechsel L, Brawanski A, Bogdahn U, Steinbrecher A. Wismeth C, et al. Among authors: koch h. J Neurooncol. 2004 May;68(1):79-86. doi: 10.1023/b:neon.0000024748.26608.2f. J Neurooncol. 2004. PMID: 15174524 Clinical Trial.

3

ROC analysis as an additional method to characterize time to event data.

Koch HJ, Hau P. Koch HJ, et al. Pathol Oncol Res. 2005;11(1):50-2. doi: 10.1007/BF03032406. Epub 2005 Mar 31. Pathol Oncol Res. 2005. PMID: 15800683 Free article.

4

Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.

Glas M, Koch H, Hirschmann B, Jauch T, Steinbrecher A, Herrlinger U, Bogdahn U, Hau P. Glas M, et al. Among authors: koch h. Oncology. 2007;72(5-6):302-7. doi: 10.1159/000113052. Epub 2008 Jan 14. Oncology. 2007. PMID: 18198491

5

Salvage therapy in patients with glioblastoma: is there any benefit?

Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgäuer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A. Hau P, et al. Among authors: koch h. Cancer. 2003 Dec 15;98(12):2678-86. doi: 10.1002/cncr.11845. Cancer. 2003. PMID: 14669289 Free article.

6

Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.

Hau P, Ruemmele P, Kunz-Schughart LA, Doerfelt A, Hirschmann B, Lohmeier A, Koch H, Mueller A, Bogdahn U, Bosserhoff AK. Hau P, et al. Among authors: koch h. Oncol Rep. 2004 Dec;12(6):1355-64. Oncol Rep. 2004. PMID: 15547763

7

Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.

Hau P, Kunz-Schughart LA, Rümmele P, Arslan F, Dörfelt A, Koch H, Lohmeier A, Hirschmann B, Müller A, Bogdahn U, Bosserhoff AK. Hau P, et al. Among authors: koch h. J Neurooncol. 2006 Mar;77(1):1-7. doi: 10.1007/s11060-005-9000-5. Epub 2005 Nov 15. J Neurooncol. 2006. PMID: 16292494

8

Seasonal patterns of birth in patients with glioblastoma.

Koch HJ, Klinkhammer-Schalke M, Hofstädter F, Bogdahn U, Hau P. Koch HJ, et al. Chronobiol Int. 2006;23(5):1047-52. doi: 10.1080/07420520600921088. Chronobiol Int. 2006. PMID: 17050217

9

Ultrasonic contrast agents in transcranial perfusion sonography (TPS) for follow-up of patients with high grade gliomas.

Ickenstein GW, Valaikiene J, Koch H, Hau P, Erban P, Schlachetzki F. Ickenstein GW, et al. Among authors: koch h. Ultrason Sonochem. 2008 Apr;15(4):510-516. doi: 10.1016/j.ultsonch.2007.08.009. Epub 2007 Sep 14. Ultrason Sonochem. 2008. PMID: 18029220 Free article.

10

[Spinal and cerebral leptomeningeal seeding from a melanocytoma of the cerebello-pontine angle].

Koch HJ, Roeber S, Zimmermann UW, Schäfer C, Villarrubia V, Kuchelmeister K, Schachenmayr W, Bogdahn U, Steinbrecher A. Koch HJ, et al. Wien Med Wochenschr. 2005 Aug;155(15-16):360-4. doi: 10.1007/s10354-005-0199-8. Wien Med Wochenschr. 2005. PMID: 16160923 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,390 results

Search Page

Filters